Brandywine Global Investment Management’s Harvard Bioscience HBIO Stock Holding History

Brandywine Global Investment Management’s Portfolio HBIO Stock Details HBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,330	Closed	-$44K	–	922
2017 Q4	$44K	Buy	+1,330	New	+$44.9K	﹤0.01%	787
2015 Q1	–	Sell	-924	Closed	-$53K	–	1004
2014 Q4	$53K	Hold	924	–	–	﹤0.01%	865
2014 Q3	$38K	Sell	924 -9	-1%	-$414	﹤0.01%	858
2014 Q2	$43K	Sell	933 -500	-35%	-$21K	﹤0.01%	849
2014 Q1	$68K	Buy	+1,433	New	+$65.2K	﹤0.01%	833

Other funds holding HBIO

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Brandywine Global Investment Management's HBIO Position: Q1 2018 in Review

Brandywine Global Investment Management sold out of Harvard Bioscience (HBIO) in Q1 2018, closing a stake of 1,330 shares — an estimated $44K sold.

Brandywine Global Investment Management first reported a position in HBIO in Q1 2014 and held it in 5 quarters. The position peaked at $68K in Q1 2014. 71 funds tracked by Wall St. Rank hold HBIO as of Q1 2018.

Brandywine Global Investment Management reported no remaining Harvard Bioscience position as of Q1 2018 after selling out during the quarter.
Brandywine Global Investment Management sold 1,330 Harvard Bioscience shares in Q1 2018, an estimated $44K.
Brandywine Global Investment Management first reported a position in Harvard Bioscience in Q1 2014 and held it in 5 quarters.
Brandywine Global Investment Management's Harvard Bioscience position peaked at $68K in Q1 2014.
71 funds tracked by Wall St. Rank held Harvard Bioscience as of Q1 2018.

Based on Brandywine Global Investment Management's 13F filing for Q1 2018, filed 15 May 2018.